![](/img/cover-not-exists.png)
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer
J.D. WRIGHT, A.A. SECORD, T.M. NUMNUM, R.P. ROCCONI, M.A. POWELL, A. BERCHUCK, R.D. ALVAREZ, R.K. GIBB, K. TRINKAUS, J.S. RADER, D.G. MUTCHVolume:
18
Year:
2008
Language:
english
Pages:
7
DOI:
10.1111/j.1525-1438.2007.01027.x
File:
PDF, 145 KB
english, 2008